Clinical Trials
4 trialsNCT00615784 2020-12-17
UPCC04407
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT00425477 2018-10-05
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00316030 2016-06-08
Study of Bexarotene in Patients With Acute Myeloid Leukemia
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01001143 2014-07-29
AML
Washington University School of Medicine
Phase 1 Completed